CDK5 and neoplasm: Importantly, we demonstrated that aPBAE/Cas9-Cdk5 treatment elicited strong T cell-mediated immune responses in tumor microenvironment and that the population of CD8+ T cells was significantly increased while regulatory T cells (Tregs) was decreased.